About PSM
Partnership for Safe Medicines Statement on Foreign Drug Importation Efforts in the U.S. Senate (updated)
Washington, D.C. (Updated June 13, 2022) – Shabbir Imber Safdar, executive director of the Partnership for Safe Medicines, released the following statement in advance of the Senate HELP Committee’s June 14th Executive Session. “The amendments offered to include foreign drug importation in S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, are…
[...]Partnership for Safe Medicines Releases Anti-Counterfeit Public Service Announcement with ADAP Advocacy Association
Washington, D.C. (April 6, 2022) – The Partnership for Safe Medicines has teamed up with the ADAP Advocacy Association (aaa+) to educate people living with HIV on ways they can protect themselves against potential counterfeit medications.
[...]Partnership for Safe Medicines Statement on Synthetic Opioid Trafficking Commission Report
Washington, D.C. (August 12, 2021) – Shabbir Safdar, executive director of the Partnership for Safe Medicines, released the following statement in response to the Synthetic Opioid Trafficking Commission’s Final Report
[...]How can families affected by fentanyl or fake medicines become advocates in 2022?
Has your family been affected by fentanyl or fake pills? Learn about opportunities in 2022 to advocate to address the crisis in this webinar about federal legislation this year.
[...]Dr. Marv Shepherd, founding member of PSM, announces retirement from the board
The Board of Directors for the Partnership for Safe Medicines (PSM) announces the retirement of Board President Dr. Marvin D. Shepherd.
[...]Partnership for Safe Medicines Statement on Pres. Biden’s Remarks on Lowering Prescription Drug Costs
Washington, D.C. (August 12, 2021) – Shabbir Safdar, executive director of the Partnership for Safe Medicines, released the following statement in response to President Biden’s remarks about lowering healthcare costs for Americans
[...]Partnership for Safe Medicines Statement on the Centers for Disease Control and Prevention’s Drug Death Totals for 2020
Shabbir Safdar, executive director of the Partnership for Safe Medicines (PSM), released this statement in response to the Centers for Disease Control and Prevention’s (CDC) preliminary statistics for the number of Americans whose deaths in 2020 involved drugs
[...]Partnership for Safe Medicines Statement on Biden Administration Executive Order to Foster Competition
Shabbir Safdar, executive director of the Partnership for Safe Medicines, released this statement in response to President Biden’s executive order to foster competition, which favors importation of prescription drugs from Canada.
[...]Illegal Pill Presses Pose Serious, Nationwide Threat to American Patients and Communities
The Partnership for Safe Medicines and the National Association of Drug Diversion Investigators have released an update to 2019’s Illegal Pill Presses: An Overlooked Threat to American Patients.
Since the initial report, fentanyl deaths are higher than ever and these pills – created by clandestine pill presses around the globe – continue to be sold on the streets and on the dark web.
[...]Partnership for Safe Medicines’ Statement on Congressional Action to Permanently Schedule Fentanyl-Related Analogues and Substances
Shabbir Safdar, Executive Director of the Partnership for Safe Medicines, released the following statement today in response to Congressional actions to permanently scheduling illicitly manufactured and deadly fentanyl…
[...]